Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Exiqon Introduces microRNA qPCR Panels for Stem Cell Research

Published: Wednesday, April 18, 2012
Last Updated: Wednesday, April 18, 2012
Bookmark and Share
Scientists to apply a panel of qPCR microRNA assays optimized for embryonic and induced pluripotent research.

Exiqon A/S has launched microRNA qPCR panels for stem cell research.
The new Stem Cell Focus microRNA PCR Panels allow scientists interested in stem cell research to apply a panel of qPCR microRNA assays optimized for embryonic and induced pluripotent research.

The 85 qPCR and 11 control assays have been experimentally optimized and validated to fit the needs of researchers interested in differentiation, proliferation, development and homeostasis of stem cells.

Recent research has documented the importance of microRNAs in the differentiation of stem cells as microRNAs are directly involved in determining the fate of the undifferentiated stem cells and in the process of inducing pluripotency of differentiated cells.

The Stem Cell Focus microRNA PCR Panels offered by Exiqon are perfectly suited for testing the degree and type of differentiation as well as the quality of the differentiation.

In a comment, Senior Vice President Sales & Marketing Henrik M. Pfundheller said: “We understand from our customers that they only have access to very limited sample material. We are therefore offering a product that only requires a 10 µl reaction volume and can detect down to 5 copies of microRNAs which is unprecedented in the market”.

He added: “Also microRNAs with high sequence content of A and T that are normally hard to detect are readily detected due to the inclusion of LNA™ in the PCR primers”.

The Stem Cell Focus microRNA PCR Panels are based on the most sensitive microRNA qPCR platform available with required sample input of as little as 1 pg of total RNA without any need for pre-amplification and thus avoiding risk of introducing bias in the generation of cDNA due to the unique universal RT step.

All major brands of qPCR instruments are supported by the Stem Cell Focus microRNA PCR Panels including instruments for both 96 and 384 well array formats.

The Stem Cell Focus microRNA PCR Panels are fully compatible with all other products in the miRCURY LNA™ Universal RT microRNA PCR system product line including the data analysis software. The entire work process from sample to data can be completed in 3 hours.

Exiqon offers a complete range of PCR products for the microRNA analysis which includes ready-to-use panels for genome-wide screening of human, mouse and rat microRNAs, numerous other focus panels, the fully flexible Pick & Mix panels, spike in kits, as well as RT and Master Mix kits, sample preparation and a unique qPCR data analysis software.

If customers have identified proprietary microRNAs and would like to take advantage of Exiqon’s proprietary LNA™ chemistry and unique RT technology, Exiqon also offers an easy to use design software for high quality design of custom microRNA qPCR assays.

The miRCURY LNA™ microRNA PCR is also accessible via Exiqon Services.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Exiqon Announces 2012 Grant Program for MicroRNA Research
The company announced the launch of its 2012 global research grant program, open to researchers from academic and non-profit institutions.
Thursday, January 05, 2012
Exiqon and Roswell Park Sign Center of Excellence Agreement
Roswell Park to provide real-time PCR services based on Exiqon’s miRCURY LNA™ Universal RT microRNA PCR product line.
Friday, October 07, 2011
Exiqon to Present New Data at AACR Conference
Data from company’s diagnostic program on early detection of colorectal cancer in plasma has been selected for oral presentation at the 102nd AACR.
Monday, April 11, 2011
Scientific News
Ancient Viral Molecules Essential for Human Development
Genetic material from ancient viral infections is critical to human development, according to researchers at the Stanford University School of Medicine.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Best Test to Diagnose Strangles in Horses Identified
New research by Dr. Ashley Boyle of New Bolton Center’s Equine Field Service team shows that the best method for diagnosing Strangles in horses is to take samples from a horse’s guttural pouch and analyze them using a loop-mediated amplification (LAMP) polymerase chain reaction (PCR) test.
Tardigrade's Are DNA Master Thieves
Tardigrades, nearly microscopic animals that can survive the harshest of environments, including outer space, hold the record for the animal that has the most foreign DNA.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
Detecting When Hormone Treatment for Breast Cancer Stops Working
Scientists have developed a highly sensitive blood test that can spot when breast cancers become resistant to standard hormone treatment, and have demonstrated that this test could guide further treatment.
Packaging and Unpacking of the Genome
New research improves understanding of the importance of histone replacement.
New Way to Find DNA Damage
University of Utah chemists devised a new way to detect chemical damage to DNA that sometimes leads to genetic mutations responsible for many diseases, including various cancers and neurological disorders.
How Different Treatments for Crohn's Effect the Microbiome
Different treatments for Crohn's disease in children affects their gut microbes in distinct ways, which has implications for future development of microbial-targeted therapies for these patients, according to a study led by researchers from the Perelman School of Medicine at the University of Pennsylvania.
Charting the 'Genomic Biography' of Leukemia
A new study by scientists at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard offers a glimpse of the wealth of information that can be gleaned by combing the genome of a large collection of leukemia tissue samples.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos